Predictive Oncology Income After Taxes 2010-2025 | POAI
Predictive Oncology income after taxes from 2010 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Predictive Oncology Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $-11 |
| 2023 | $-12 |
| 2022 | $-26 |
| 2021 | $-20 |
| 2020 | $-26 |
| 2019 | $-19 |
| 2018 | $-10 |
| 2017 | $-6 |
| 2016 | $-7 |
| 2015 | $-5 |
| 2014 | $-7 |
| 2013 | $-9 |
| 2012 | $-7 |
| 2011 | $-4 |
| 2010 | $-1 |
| 2009 | $-3 |
| Predictive Oncology Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-2 |
| 2024-12-31 | $-2 |
| 2024-09-30 | $-2 |
| 2024-06-30 | $-3 |
| 2024-03-31 | $-4 |
| 2023-12-31 | $-2 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-8 |
| 2022-09-30 | $-4 |
| 2022-06-30 | $-10 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-8 |
| 2021-09-30 | $-5 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-4 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-6 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-5 |
| 2019-12-31 | $-14 |
| 2019-09-30 | $-4 |
| 2019-06-30 | $1 |
| 2019-03-31 | $-3 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-3 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-1 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $-3 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-1 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $0 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $-2 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-1 |
| 2013-03-31 | $-2 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-2 |
| 2012-03-31 | $-1 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $-1 |
| 2009-12-31 | $0 |
| 2009-09-30 | $-1 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.644B | 58.07 |
| Doximity (DOCS) | United States | $11.655B | 53.96 |
| Hims & Hers Health (HIMS) | United States | $11.295B | 117.35 |
| Tempus AI (TEM) | United States | $9.675B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.275B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.775B | 58.99 |
| Hinge Health (HNGE) | United States | $3.572B | 0.00 |
| Privia Health (PRVA) | United States | $2.516B | 172.00 |
| Enovis (ENOV) | United States | $1.765B | 9.84 |
| Phreesia (PHR) | United States | $1.591B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.517B | 0.00 |
| 10x Genomics (TXG) | United States | $1.505B | 0.00 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.461B | 67.89 |
| Evolent Health (EVH) | United States | $1.335B | 113.70 |
| Omnicell (OMCL) | United States | $1.276B | 22.51 |
| Claritev (CTEV) | United States | $0.717B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.435B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.321B | 713.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.213B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.125B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.120B | 0.00 |
| Pulmonx (LUNG) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |